How would you proceed with the management of a healthy patient with stage IV grade 3 endometrioid uterine cancer metastatic to the right diaphragm and other peritoneal surfaces?

Community
Company
News
Contact Us
Sign in

Topics: Gynecologic Cancers • Endometrial Cancer

No mesenteric/small bowel/lesser sac involvement on imaging

Answer from: at Academic Institution

Enroll the patient in a clinical protocol.

11442

Related Questions

Is it ever acceptable to treat low pelvis (vs. whole pelvis) for an early vaginal recurrence of endometrial cancer?

How would you approach the management of a women who was incidentally found to have a deeply invasive low-grade endometrial carcinoma after she underwent a supracervical hysterectomy with placement of mesh for uterine prolapse?

What are your top takeaways in Gynecologic Cancers from ASCO 2023?

How do you manage a patient with widely metastatic serous endometrial cancer whose disease is stable after completion of 6 cycles of chemotherapy + immunotherapy?

What dose and target volume do you use for neoadjuvant chemoRT in a patient with a locally advanced uterine/endometrial cancer involving parametria, cervix, and the uterine fundus (no side wall involvement) requiring downstage to be eligible for surgery?

How would you treat recurrent endometrial carcinoma with a presentation of inguinal and external iliac adenopathy?

What do you view as the future role for the combination of durvalumab + olaparib + chemotherapy in the management of patients with advanced/recurrent endometrial cancer following the DUO-E trial results?

For a medically inoperable clinically-staged FIGO IA endometrial cancer with serous, clear cell or other non-endometrioid, high-risk histology treated with EBRT alone, would you cover elective lymph nodes, or treat the uterus alone?

What is your preferred first line systemic treatment for recurrent, metastatic, low grade, ER/PR+ pMMR endometrioid endometrial carcinoma?

Do you offer resection of oligometastatic disease for patients with recurrent uterine serous carcinoma within the pelvis following initial treatment with adjuvant chemotherapy and vaginal cuff brachytherapy?